In this section we report on United Nations Global Compact principle 10.


Novozymes seeks appropriate measures to work against all forms of corruption, including extortion and bribery. Novozymes' dedication to addressing and advancing anticorruption and business integrity aspects is embedded in our Vision, values, and company idea, Touch the World.
In support of international business integrity conventions such as the United Nations Convention Against Corruption and standards such as the principles of the United Nations Global Compact, relevant principles are integrated systematically in Novozymes’ management practices to ensure that global and local initiatives are mutually supportive. In this connection, Novozymes has developed specific policies on issues covering financial, legal, and tax issues as well as positions on business integrity, responsible purchasing, business ethics, and others.
Based on the above practices, standards, policies, and positions, the relevant boards and departments systematically monitor, report, and follow up on anticorruption and bribery at Novozymes on an ongoing basis.
In support of anticorruption management, development, and transparency, Novozymes reports on the following GRI indicators: SO 2, SO 3, SO 4, SO 5, SO 6, SO 7, and SO 8, providing a quantitative counterpart to anticorruption and business integrity reporting.


In 2011, we updated our booklet on business integrity to reflect various intergovernmental initiatives. The updated booklet was used in an internal awareness-raising campaign with a link to our new set of values. Training within the organization regarding Novozymes’ standards on business integrity also continued by means of an e-learning program, and we reached 71% coverage. Furthermore, as of 2011 we have successfully complied with all the basic reporting elements and several of the desired reporting elements that are part of the Guidance on the 10th Principle against corruption, developed by the UN Global Compact. 
Development of Business Integrity Standards
In our effort to stay in touch with both internal risks and external trends, Novozymes continuously strives to improve our standards and guidelines. As a result, we have updated our booklet on business integrity, Bribery – No thanks!, to reflect new intergovernmental initiatives such as the United Nations Convention against Corruption, OECD Conventions and Recommendations, EU conventions against corruption, and national instruments, including the US Sarbanes–Oxley Act and the UK Bribery Act. 
Successful reporting on 10th principle against corruption
Being a Global Compact participant and a LEAD company, Novozymes aims for complying with all the seven basic reporting elements and several of the desired reporting elements in the Guidance on the 10th principle against corruption, developed by the UN Global Compact and Transparency International. The reporting guidance provides a good structure for documenting our commitment, policies, implementation, and monitoring activities related to anticorruption. Reporting of these elements is integrated in our governance and management structure as illustrated above. An index of compliance with the basic reporting elements is provided in Transparency and disclosure
Successful reporting on 10th principle against corruption




Focus on distribution strategy
In 2012, the Committee on Business Integrity will focus on development of a systematic approach to follow up on distributors and agents, so as to extend the principles related to anticorruption to the value chain in which we operate. This strategy will be used to develop a clear perspective on the principles that distributors need to adhere to. Increased training and further coverage of employees are also in the pipeline for 2012.
Increased focus on desired reporting elements in the Guidance on the 10th principle against corruption
Novozymes intends to place additional focus on improving our documentation of and reporting on the additional desired reporting elements provided by the Guidance on the 10th principle against corruption. We perceive this as an opportunity to learn from best practices related to business integrity, and can gather inspiration to improve our efforts in implementation and communication of aspects related to anticorruption such as:
  • Commitment and policies: leadership commitment, commitment to international conventions, risk assessment, and management
  • Implementation: actions to encourage business partners, responsibility, accountability, and auditing
  • Monitoring: participation in anticorruption initiatives, dealing with incidents, external assurance, etc.
With a focus on distributors and agents, we intend to encourage those along the value chain to commit to and implement stronger anticorruption measures, which is linked to the desired reporting element D6. We will also focus on element D8, with increased involvement of the human resources team through training programs.